Literature DB >> 29954862

Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.

Fernando Aleman1, Netanel Tzarum2, Leopold Kong2, Kenna Nagy1, Jiang Zhu1,2, Ian A Wilson3,4,5,6, Mansun Law7.   

Abstract

Elicitation of broadly neutralizing antibodies (bnAbs) is a leading strategy in rational vaccine design against antigenically diverse pathogens. Here, we studied a panel of monoclonal antibodies (mAbs) from mice immunized with the hepatitis C virus (HCV) envelope glycoproteins E1E2. Six of the mAbs recognize the conserved E2 antigenic site 412-423 (AS412) and cross-neutralize diverse HCV genotypes. Immunogenetic and structural analysis revealed that the antibodies originated from two different germline (GL) precursors and bind AS412 in a β-hairpin conformation. Intriguingly, the anti-HCV activity of one antibody lineage is associated with maturation of the light chain (LC), whereas the other lineage is dependent on heavy-chain (HC) maturation. Crystal structures of GL precursors of the LC-dependent lineage in complex with AS412 offer critical insights into the maturation process of bnAbs to HCV, providing a scientific foundation for utilizing the mouse model to study AS412-targeting vaccine candidates.

Entities:  

Keywords:  E1E2 glycoproteins; HCV vaccine; antibody germline precursors; broadly neutralizing antibodies; hepatitis C Virus

Mesh:

Substances:

Year:  2018        PMID: 29954862      PMCID: PMC6055136          DOI: 10.1073/pnas.1802378115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  46 in total

Review 1.  Capitalizing on knowledge of hepatitis C virus neutralizing epitopes for rational vaccine design.

Authors:  Leopold Kong; Kelli N Jackson; Ian A Wilson; Mansun Law
Journal:  Curr Opin Virol       Date:  2015-04-29       Impact factor: 7.090

2.  Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.

Authors:  Leopold Kong; David E Lee; Rameshwar U Kadam; Tong Liu; Erick Giang; Travis Nieusma; Fernando Garces; Netanel Tzarum; Virgil L Woods; Andrew B Ward; Sheng Li; Ian A Wilson; Mansun Law
Journal:  Proc Natl Acad Sci U S A       Date:  2016-10-24       Impact factor: 11.205

3.  Cooperativity in virus neutralization by human monoclonal antibodies to two adjacent regions located at the amino terminus of hepatitis C virus E2 glycoprotein.

Authors:  Zhenyong Keck; Wenyan Wang; Yong Wang; Patrick Lau; Thomas H R Carlsen; Jannick Prentoe; Jinming Xia; Arvind H Patel; Jens Bukh; Steven K H Foung
Journal:  J Virol       Date:  2012-10-24       Impact factor: 5.103

Review 4.  Viral evasion and challenges of hepatitis C virus vaccine development.

Authors:  Brian G Pierce; Zhen-Yong Keck; Steven Kh Foung
Journal:  Curr Opin Virol       Date:  2016-09-19       Impact factor: 7.090

5.  Determination of the human antibody response to the epitope defined by the hepatitis C virus-neutralizing monoclonal antibody AP33.

Authors:  Alexander W Tarr; Ania M Owsianka; Dhanya Jayaraj; Richard J P Brown; Timothy P Hickling; William L Irving; Arvind H Patel; Jonathan K Ball
Journal:  J Gen Virol       Date:  2007-11       Impact factor: 3.891

6.  Structural flexibility of a conserved antigenic region in hepatitis C virus glycoprotein E2 recognized by broadly neutralizing antibodies.

Authors:  Annalisa Meola; Alexander W Tarr; Patrick England; Luke W Meredith; C Patrick McClure; Steven K H Foung; Jane A McKeating; Jonathan K Ball; Felix A Rey; Thomas Krey
Journal:  J Virol       Date:  2014-12-03       Impact factor: 5.103

7.  Human monoclonal antibodies to a novel cluster of conformational epitopes on HCV E2 with resistance to neutralization escape in a genotype 2a isolate.

Authors:  Zhen-yong Keck; Jinming Xia; Yong Wang; Wenyan Wang; Thomas Krey; Jannick Prentoe; Thomas Carlsen; Angela Ying-Jian Li; Arvind H Patel; Stanley M Lemon; Jens Bukh; Felix A Rey; Steven K H Foung
Journal:  PLoS Pathog       Date:  2012-04-12       Impact factor: 6.823

Review 8.  The hepatitis C virus glycan shield and evasion of the humoral immune response.

Authors:  François Helle; Gilles Duverlie; Jean Dubuisson
Journal:  Viruses       Date:  2011-10-14       Impact factor: 5.048

9.  Monoclonal Antibodies Directed toward the Hepatitis C Virus Glycoprotein E2 Detect Antigenic Differences Modulated by the N-Terminal Hypervariable Region 1 (HVR1), HVR2, and Intergenotypic Variable Region.

Authors:  Yousef Alhammad; Jun Gu; Irene Boo; David Harrison; Kathleen McCaffrey; Patricia T Vietheer; Stirling Edwards; Charles Quinn; Fásseli Coulibaly; Pantelis Poumbourios; Heidi E Drummer
Journal:  J Virol       Date:  2015-09-16       Impact factor: 5.103

10.  HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies.

Authors:  Jon M Steichen; Daniel W Kulp; Talar Tokatlian; Amelia Escolano; Pia Dosenovic; Robyn L Stanfield; Laura E McCoy; Gabriel Ozorowski; Xiaozhen Hu; Oleksandr Kalyuzhniy; Bryan Briney; Torben Schiffner; Fernando Garces; Natalia T Freund; Alexander D Gitlin; Sergey Menis; Erik Georgeson; Michael Kubitz; Yumiko Adachi; Meaghan Jones; Andrew A Mutafyan; Dong Soo Yun; Christian T Mayer; Andrew B Ward; Dennis R Burton; Ian A Wilson; Darrell J Irvine; Michel C Nussenzweig; William R Schief
Journal:  Immunity       Date:  2016-09-08       Impact factor: 31.745

View more
  6 in total

Review 1.  Hepatitis C Virus Envelope Glycoproteins: A Balancing Act of Order and Disorder.

Authors:  Samantha A Yost; Yuanyuan Wang; Joseph Marcotrigiano
Journal:  Front Immunol       Date:  2018-08-24       Impact factor: 7.561

2.  Flexibility and intrinsic disorder are conserved features of hepatitis C virus E2 glycoprotein.

Authors:  Lenka Stejskal; William D Lees; David S Moss; Machaela Palor; Richard J Bingham; Adrian J Shepherd; Joe Grove
Journal:  PLoS Comput Biol       Date:  2020-02-28       Impact factor: 4.475

Review 3.  From Structural Studies to HCV Vaccine Design.

Authors:  Itai Yechezkel; Mansun Law; Netanel Tzarum
Journal:  Viruses       Date:  2021-05-04       Impact factor: 5.818

Review 4.  Structural and Biophysical Characterization of the HCV E1E2 Heterodimer for Vaccine Development.

Authors:  Eric A Toth; Andrezza Chagas; Brian G Pierce; Thomas R Fuerst
Journal:  Viruses       Date:  2021-05-29       Impact factor: 5.048

5.  Specific Antibodies Induced by Immunization with Hepatitis B Virus-Like Particles Carrying Hepatitis C Virus Envelope Glycoprotein 2 Epitopes Show Differential Neutralization Efficiency.

Authors:  Anna Czarnota; Anna Offersgaard; Anne Finne Pihl; Jannick Prentoe; Jens Bukh; Judith Margarete Gottwein; Krystyna Bieńkowska-Szewczyk; Katarzyna Grzyb
Journal:  Vaccines (Basel)       Date:  2020-06-10

6.  Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms.

Authors:  Christian B Billesbølle; Caleigh M Azumaya; Rachael C Kretsch; Alexander S Powers; Shane Gonen; Simon Schneider; Tara Arvedson; Ron O Dror; Yifan Cheng; Aashish Manglik
Journal:  Nature       Date:  2020-08-19       Impact factor: 69.504

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.